Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neha Mehta

Showing results (121-130 of 158) with videos related to

Pageof 16
Sort By:
Transplantation Direct|October 30, 2024
The Post-transplant Lymphoproliferative Disorders-Metagenomic Shotgun Microbial Sequencing (PTLD-MSMS) Study Methods and ProtocolVikas R Dharnidharka, Kristine M Wylie, Todd N Wylie, et al.
Blood|July 3, 2020
CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomasMargery Gang, Nancy D Marin, Pamela Wong, et al.
Blood Advances|August 19, 2025
Association of PET4 Response With Outcomes of BV-CHP vs CHOP in the ECHELON-2 Trial in CD30+ Peripheral T-cell LymphomaSwaminathan P Iyer, Neha Mehta-Shah, Ranjana H Advani, et al.
Environmental Microbiology|April 12, 2026
Intracellular Amorphous Calcium Carbonate Biomineralization in Methanotrophic Gammaproteobacteria Was Acquired by Horizontal Gene Transfer From CyanobacteriaKarim Benzerara, Maxime Millet, Fériel Skouri-Panet, et al.
American Journal of Hematology|July 12, 2021
Romidepsin and lenalidomide-based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohortsNeha Mehta-Shah, Matthew A Lunning, Alison J Moskowitz, et al.
Blood Advances|July 26, 2023
Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303David A Russler-Germain, Kilannin Krysiak, Cody Ramirez, et al.
Blood|February 9, 2026
A Randomized Phase 2 Study of Ipilimumab, Nivolumab, and Brentuximab Vedotin in Patients with Relapsed Hodgkin LymphomaCatherine Diefenbach, Opeyemi Jegede, Victoria Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2023
Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell LymphomaJulio C Chavez, Francine M Foss, Basem M William, et al.
The Lancet. Oncology|November 1, 2024
Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 studyPier Luigi Zinzani, Koji Izutsu, Neha Mehta-Shah, et al.
Blood Advances|January 31, 2022
Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method surveyR Andrew Harkins, Sharvil P Patel, Michelle J Lee, et al.
Pageof 16

Showing results (121-130 of 158) with videos related to

Sort By:
Pageof 16
Transplantation Direct|October 30, 2024
The Post-transplant Lymphoproliferative Disorders-Metagenomic Shotgun Microbial Sequencing (PTLD-MSMS) Study Methods and ProtocolVikas R Dharnidharka, Kristine M Wylie, Todd N Wylie, et al.
Blood|July 3, 2020
CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomasMargery Gang, Nancy D Marin, Pamela Wong, et al.
Blood Advances|August 19, 2025
Association of PET4 Response With Outcomes of BV-CHP vs CHOP in the ECHELON-2 Trial in CD30+ Peripheral T-cell LymphomaSwaminathan P Iyer, Neha Mehta-Shah, Ranjana H Advani, et al.
Environmental Microbiology|April 12, 2026
Intracellular Amorphous Calcium Carbonate Biomineralization in Methanotrophic Gammaproteobacteria Was Acquired by Horizontal Gene Transfer From CyanobacteriaKarim Benzerara, Maxime Millet, Fériel Skouri-Panet, et al.
American Journal of Hematology|July 12, 2021
Romidepsin and lenalidomide-based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohortsNeha Mehta-Shah, Matthew A Lunning, Alison J Moskowitz, et al.
Blood Advances|July 26, 2023
Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303David A Russler-Germain, Kilannin Krysiak, Cody Ramirez, et al.
Blood|February 9, 2026
A Randomized Phase 2 Study of Ipilimumab, Nivolumab, and Brentuximab Vedotin in Patients with Relapsed Hodgkin LymphomaCatherine Diefenbach, Opeyemi Jegede, Victoria Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2023
Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell LymphomaJulio C Chavez, Francine M Foss, Basem M William, et al.
The Lancet. Oncology|November 1, 2024
Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 studyPier Luigi Zinzani, Koji Izutsu, Neha Mehta-Shah, et al.
Blood Advances|January 31, 2022
Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method surveyR Andrew Harkins, Sharvil P Patel, Michelle J Lee, et al.
Pageof 16